InvestorsHub Logo
Followers 3157
Posts 962004
Boards Moderated 181
Alias Born 09/04/2000

Re: mick post# 2516

Sunday, 07/17/2022 6:18:09 PM

Sunday, July 17, 2022 6:18:09 PM

Post# of 2538
Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster • GlobeNewswire Inc. • 06/27/2022 10:04:28 AM
Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DVAX News